| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.01 | 0.7 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.7 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.024 | 0.8 |